Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06455488 · ClinicalTrials.gov registry record
MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry
A clinical trial of Ventricular Tachycardia, sponsored by CorVita Science Foundation.
- Recruiting
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT06455488: Recruiting study of Ventricular Tachycardia, sponsored by CorVita Science Foundation.
NCT06455488 is a study of Ventricular Tachycardia that is actively recruiting participants, run by CorVita Science Foundation. The registered enrollment target is 130 participants, below the 284-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06455488, a study of Ventricular Tachycardia, is actively recruiting participants, sponsored by CorVita Science Foundation.
- RECRUITING
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.
Primary Outcome
The natural progression of v-tach will be assessed through medical record review
Conditions Studied
Interventions
- PROCEDURE Ventricular Tachycardia Ablation
- DEVICE ICD Implant
- DRUG Antiarrhythmic drug
- DIAGNOSTIC_TEST EKG
- DIAGNOSTIC_TEST Cardioversion
Study Locations (1)
Illinois
- Corvita Science Foundation - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2020-07-20 |
| Est. Completion | 2030-07-20 |
What NCT06455488 shows while recruiting
NCT06455488 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 284-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 5 interventions - of which Ventricular Tachycardia Ablation is the first listed.
NCT06455488 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06455488 about?
NCT06455488 is a clinical study titled "MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry". Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.
What is the current status of trial NCT06455488?
This trial is currently recruiting. The enrollment target is 130 participants. The study started on 2020-07-20. Estimated completion is 2030-07-20.
What conditions does trial NCT06455488 study?
This clinical trial studies the following conditions: Ventricular Tachycardia.
What interventions are being tested in trial NCT06455488?
The interventions under investigation include: Ventricular Tachycardia Ablation (PROCEDURE), ICD Implant (DEVICE), Antiarrhythmic drug (DRUG), EKG (DIAGNOSTIC_TEST), Cardioversion (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06455488?
This trial is sponsored by CorVita Science Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06455488 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06455488's enrollment target sits among peer trials
130 13th of 28 higher than 16 of 28 other Ventricular Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventricular Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ventricular Tachycardia Mechanisms
RECRUITING · NA
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
RECRUITING
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI